EVALUATION OF THE CLINICAL AND MICROBIOLOGICAL EFFICACY OF N-ACETILCISTEINA 600 MG, IN COMBINATION TO CEFPODOXIMA PROXETILE, IN THE THERAPY OF THE INFECTIONS OF THE HIGH RESPIRATORY WAYS IN ADULT PATIENTS CLINICAL STUDY MULTICENTRIC, TO GROUPS PARALLELS, DOUBLE - BLIND VS PLACEBO.

Trial Profile

EVALUATION OF THE CLINICAL AND MICROBIOLOGICAL EFFICACY OF N-ACETILCISTEINA 600 MG, IN COMBINATION TO CEFPODOXIMA PROXETILE, IN THE THERAPY OF THE INFECTIONS OF THE HIGH RESPIRATORY WAYS IN ADULT PATIENTS CLINICAL STUDY MULTICENTRIC, TO GROUPS PARALLELS, DOUBLE - BLIND VS PLACEBO.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2012

At a glance

  • Drugs Acetylcysteine; Cefpodoxime proxetil
  • Indications Bacterial infections; Pharyngitis; Respiratory tract infections; Rhinosinusitis; Tonsillitis
  • Focus Therapeutic Use
  • Sponsors Zambon Company SpA
  • Most Recent Events

    • 22 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top